Project/Area Number |
26893264
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Hematology
|
Research Institution | Juntendo University |
Principal Investigator |
|
Project Period (FY) |
2014-08-29 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | PCAF / 急性前骨髄球性白血病(APL) / 全トランスレチノイン酸(ATRA) / 分化誘導療法 / ヒストンアセチル基転移酵素 / 蛋白質アセチル化 / 急性前骨髄球性白血病 / ATRA / 好中球分化 / 全トランスレチノイン酸 / 分化誘導 |
Outline of Final Research Achievements |
All-trans retinoic acid (ATRA) induces granulocytic differentiation in acute promyelocytic leukemia (APL) cells, however, its detailed molecular mechanism remains unclear. Here, we showed that the overexpression of a histone acetyltransferase PCAF induced the expression of the granulocytic differentiation marker at the mRNA level, suggesting that PCAF is essential for APL cell differentiation. In addition, we found that ATRA acetylated the PCAF substrates while ATRA induced granulocytic differentiation in leukemic cells. Furthermore, PCAF regulated the downstream target gene expression of ATRA. These observations suggested that ATRA induced granulocytic differentiation in APL cells through the PCAF-induced protein acetylation and the PCAF-regulated downstream target gene expression.
|